681 related articles for article (PubMed ID: 3758906)
21. Anti-hepatitis delta virus seroprevalence and risk factors in patients with hepatitis B in Southeast Turkey.
Celen MK; Ayaz C; Hosoglu S; Geyik MF; Ulug M
Saudi Med J; 2006 May; 27(5):617-20. PubMed ID: 16680248
[TBL] [Abstract][Full Text] [Related]
22. Receptors for polymerized human serum albumin and other hepatitis B virus markers during acute hepatitis B--predictive value of the outcome of the disease.
Mora I; Porres JC; Bartolome FJ; Hernandez Guio C; Gutiez J; Carreño V
Hepatogastroenterology; 1986 Dec; 33(6):250-4. PubMed ID: 3026941
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers.
Brunetto MR; Oliveri F; Colombatto P; Moriconi F; Ciccorossi P; Coco B; Romagnoli V; Cherubini B; Moscato G; Maina AM; Cavallone D; Bonino F
Gastroenterology; 2010 Aug; 139(2):483-90. PubMed ID: 20451520
[TBL] [Abstract][Full Text] [Related]
24. Rational use of polymerase chain reaction--based detection of viral genomes in patients with serologic markers of hepatitis B or C virus infection.
Pfeffel F; Oesterreicher C; Penner E; Ferenci P; Sillaber C; Fiedler R; Müller C
Wien Klin Wochenschr; 1997 Jan; 109(1):20-4. PubMed ID: 9037744
[TBL] [Abstract][Full Text] [Related]
25. What is the role of serology for the study of chronic hepatitis B virus infection in the age of molecular biology?
Galli C; Orlandini E; Penzo L; Badiale R; Caltran G; Valverde S; Gessoni G
J Med Virol; 2008 Jun; 80(6):974-9. PubMed ID: 18428144
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis B virus concentrations in serum determined by sensitive quantitative assays in patients with established chronic hepatitis delta virus infection.
Sakugawa H; Nakasone H; Nakayoshi T; Kawakami Y; Yamashiro T; Maeshiro T; Kinjo F; Saito A; Zukeran H
J Med Virol; 2001 Nov; 65(3):478-84. PubMed ID: 11596082
[TBL] [Abstract][Full Text] [Related]
27. Genotype, phylogenetic analysis, and transmission pattern of occult hepatitis B virus (HBV) infection in families of asymptomatic HBsAg carriers.
Datta S; Banerjee A; Chandra PK; Chowdhury A; Chakravarty R
J Med Virol; 2006 Jan; 78(1):53-9. PubMed ID: 16299727
[TBL] [Abstract][Full Text] [Related]
28. Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis.
Sagnelli E; Coppola N; Scolastico C; Filippini P; Santantonio T; Stroffolini T; Piccinino F
Hepatology; 2000 Nov; 32(5):1106-10. PubMed ID: 11050062
[TBL] [Abstract][Full Text] [Related]
29. [Significance of detailed Hepatitis B virus marker studies in chronic liver diseases].
Horváth G; Tolvaj G; Dávid K
Orv Hetil; 1992 Jul; 133 Suppl 1():9-13. PubMed ID: 1630808
[TBL] [Abstract][Full Text] [Related]
30. Infection with hepatitis A, B, C, and delta viruses among patients with acute hepatitis in Mongolia.
Tsatsralt-Od B; Takahashi M; Endo K; Buyankhuu O; Baatarkhuu O; Nishizawa T; Okamoto H
J Med Virol; 2006 May; 78(5):542-50. PubMed ID: 16555292
[TBL] [Abstract][Full Text] [Related]
31. Prevalence and clinical significance of hepatitis D virus co-infection in patients with chronic hepatitis B in Korea.
Kim HS; Kim SJ; Park HW; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
J Med Virol; 2011 Jul; 83(7):1172-7. PubMed ID: 21541950
[TBL] [Abstract][Full Text] [Related]
32. Prevalence and determinants of hepatitis B virus markers in pregnant women in West Java, Indonesia.
Reniers J; Vranckx R; Ngantung W; Sugita E; Meheus A
J Trop Med Hyg; 1987 Oct; 90(5):249-53. PubMed ID: 3669127
[TBL] [Abstract][Full Text] [Related]
33. [Follow-up of chronic hepatitis B carriers. Serological course and risk of reactivation].
Bujanda L; García Bengoechea M; Cilla G; Gil I; yArenas JI
Rev Esp Enferm Dig; 1996 May; 88(5):335-9. PubMed ID: 8764540
[TBL] [Abstract][Full Text] [Related]
34. Low frequency of precore mutants in anti-hepatitis B e antigen positive subjects with chronic hepatitis B virus infection in Chennai, Southern India.
Shanmugam S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Shankar EM; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
J Microbiol Biotechnol; 2008 Oct; 18(10):1722-8. PubMed ID: 18955826
[TBL] [Abstract][Full Text] [Related]
35. Risk of hepatitis B surface antigen seroreversion after allogeneic hematopoietic SCT.
Viganò M; Vener C; Lampertico P; Annaloro C; Pichoud C; Zoulim F; Facchetti F; Poli F; Scalamogna M; Deliliers GL; Colombo M
Bone Marrow Transplant; 2011 Jan; 46(1):125-31. PubMed ID: 20383209
[TBL] [Abstract][Full Text] [Related]
36. An outbreak of fulminant hepatitis B in immunocompromised hemodialysis patients.
Igaki N; Nakaji M; Moriguchi R; Akiyama H; Tamada F; Oimomi M; Goto T
J Gastroenterol; 2003; 38(10):968-76. PubMed ID: 14614604
[TBL] [Abstract][Full Text] [Related]
37. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.
Sheng WH; Kao JH; Chen PJ; Huang LM; Chang SY; Sun HY; Hung CC; Chen MY; Chang SC
Clin Infect Dis; 2007 Nov; 45(9):1221-9. PubMed ID: 17918088
[TBL] [Abstract][Full Text] [Related]
38. Occult hepatitis B in the genotype H-infected Nahuas and Huichol native Mexican population.
Roman S; Tanaka Y; Khan A; Kurbanov F; Kato H; Mizokami M; Panduro A
J Med Virol; 2010 Sep; 82(9):1527-36. PubMed ID: 20648606
[TBL] [Abstract][Full Text] [Related]
39. [Natural history of hepatitis B virus infection in dialysis patients: prospective study by quantitative analysis of HBV viremia].
Fabrizi F; Lunghi G; Finazzi S; Colucci P; Pagliari B; Bisegna S; Tettamanzi F; Ponticelli C
G Ital Nefrol; 2002; 19(3):294-300. PubMed ID: 12195397
[TBL] [Abstract][Full Text] [Related]
40. Clinical and epidemiological significance of hepatitis delta virus (HDV) infection in chronic HBV carriers in Portugal.
Ramalho F; Carvalho G; Bonino F; Baptista A; de Moura MC
Prog Clin Biol Res; 1987; 234():409-17. PubMed ID: 3628400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]